BA/BE Studies Market Intelligence

best-value

With this purchase you will be subscribed for a 12-month PRO membership to AI Powered Procurement Productivity Suite - Beroe LiVE.Ai

feature

 No Additional Benefits

Subscription Benefits:

  • PRO access to New Beroe LiVE*
  • Unlimited updates on the Report*
  • Supplier Watchlist for 3 suppliers*
  • Supplier Shortlisting Tool*

With this purchase you will be subscribed for a 12-month PRO membership to AI Powered Procurement Productivity Suite - Beroe LiVE.Ai

feature

*These features will be unlocked on the new Beroe LiVE when it launches (Q3, 2020)

Are you looking for answers on BA/BE Studies category?

Are you looking for answers on BA/BE Studies category?

  • What are the key trends in BA/BE Studies category?
  • Am I paying the right price?
  • Am I working with the right supplier?
  • What are the major challenges and risks in BA/BE Studies industry?
  • How is BA/BE Studies industry performing?

Over 50,000+ users trust Beroe

Report Coverage

  • Global Market Outlook
  • Global Vs. Regional CROs
  • Cost Break Up Analysis
  • Engagement and Pricing Models

Production Size

Global Production Value

$14.5 Billion.

CAGR between 2013 and 2020.

3–4 percent

Table of Contents

  1. Executive Summary
  2. COVID Impact Update
  1. Market Analysis
  2. Early Phase Market Size
  3. Spend by Therapeutic Area
  4. Drivers and Constraints
  5. Market Trends
  6. Porter’s Five Forces Analysis
  7. Outsourcing Adoption Rate
  1. Sourcing Practices
  2. Sourcing Model
  3. Engagement Models
  1. Innovation
  2. Innovations in Early Phase
  1. Sustainability
  2. Sustainability in Early Trials

Want a more detailed personalised report?

BA/BE Studies Global Market Outlook:

Market Growth: CAGR growth rate: 3–4 percent between 2013 and 2020. 2019 Market Value: $14.5 Billion.

Market Drivers:

  • High Trial Complexity
  • Patient Recruitment & Retention
  • Regulatory Landscape
  • Cost Reduction
  • Access to specialized Clinical techniques

Porter's Analysis on BA/BE Studies:

Supplier Power

  • Several acquisitions by established early phase providers of niche specialists shows the supplier base consolidation,growth in patient pool availability and the growing demand for Phase I studies among pharmaceutical companies
  • Niche specialists compete with established CROs by having access to a focused patient pool and HV studies.
  • However, since they have a smaller client base, their power is comparatively lesser than that of established players

Barriers to New Entrants

  • Increased regulatory demand, varying regional regulatory compliance, as well as the cost for conducting phase I trials make it more difficult for suppliers to pose competition to large suppliers
  • Niche specialists have a medium level of barrier as they have access to specialists population (e.g. Renal) focusing on a specific therapeutic area

Intensity of Rivalry

  • Since greater than 50 percent of engagement between pharma and Phase I provider is project based with only around 10 percent strategic in nature, there exists immense competition among the suppliers
  • The suppliers are leveraging market price through competitive discount structure, ability to provide specific patient pool to beat competition

Threat of Substitutes

  • Specialization, in terms of therapeutic areas, technology, along with bundling of support services will be the key differentiating factors among the suppliers
  • For both established and niche specialists, the patient pool availability and number of CPU beds will be the key differentiator with experience and risk considered along side

Buyer Power

  • The supplier market consists of multiple suppliers who are able to cater to several big pharmaceutical companies. Pharma companies have a greater choice and ability to switch between suppliers, hence increasing the buyer power

With this purchase you will be subscribed for a 12-month PRO membership to AI Powered Procurement Productivity Suite - Beroe LiVE.Ai

feature

Complimentary 12-month access to Beroe LiVE

Any more questions?

Get in touch with us quickly and easily.

x

COVID-19: Assess impact on your suppliers and ensure business continuity with Beroe’s WIRE
(World Instant Risk Exposure)